Drug-eluting versus plain balloon angioplasty for haemodialysis vascular access stenosis: a retrospective analysis
Angiologia e Cirurgia Vascular · 2026 · 22 (3)
DOI: 10.48750/acv.710 ↗Kurz gefasst
Fachartikel in der Zeitschrift Angiologia e Cirurgia Vascular, 2026. Verfasst von Roberto Boal und 6 weiteren Autor:innen.
Abstract (Originalsprache)
INTRODUCTION: Arteriovenous fistulas (AVFs) and grafts (AVGs) are the preferred vascular access for hemodialysis, but they often become dysfunctional because of stenosis. Although plain old balloon angioplasty (POBA) remains the standard treatment, drug-coated balloons (DEBs) have been proposed to reduce restenosis. However, their long-term efficacy in this setting remains uncertain. METHODS: We conducted a retrospective, single-center study of 96 patients who underwent index percutaneous transluminal angioplasty (PTA) for dysfunctional AVFs or AVGs between November 2018 and July 2025, comparing POBA with paclitaxel-coated DEBs. We excluded patients with prior interventions or stents. The primary endpoint was primary patency at 6 and 12 months, defined as the time from the index angioplasty to the first clinically driven reintervention at the treated lesion, thrombosis, or surgical revision. Secondary endpoints included secondary patency and overall mortality. We used Kaplan-Meier survival analysis and Cox regression. RESULTS: Of 96 patients (median age 62.5 years; 53.1% female), 81.3% had AVFs. POBA's were used in 79 cases, and DEBs in 17. Technical success was achieved in 93/96 patients (96.9%), with no significant difference between the POBA and DEB groups (96.2% vs. 100.0%; p = 1.0). Clinical success was 94.9% vs. 94.1% (p = 1.0). No significant difference in primary patency was observed between POBA and DEB at 6 months (58% vs. 43.8%) or 12 months (38% vs. 37.5%). Secondary patency and mortality rates were also similar. Multivariate analysis identified female sex as associated with an increased risk of primary patency loss (HR = 1.86; 95% CI: 1.08-3.19; p = 0.025), whereas balloon type was not associated with primary patency loss (POBA vs. DEB: HR = 1.00; 95% CI: 0.52-1.93; p = 0.991). Access type was not statistically significant (AVG vs. AVF: HR = 1.85; 95% CI: 1.00-3.45; p = 0.052). We did not include periprocedural complications in the multivariable model because of the small number of events. CONCLUSION: DEB angioplasty did not show a significant advantage over POBA in maintaining primary patency at 6 or 12 months. Female sex and procedural complications were associated with a higher risk of primary patency loss, whereas balloon type was not associated with the outcome. Access type showed a borderline, non-significant association with primary patency loss. Larger prospective studies are needed to further assess the role of DEBs in vascular access maintenance.
Schlagwörter
Zitieren
APA
Boal, R., Silva, M., Pereirinha, B., Maximiano, P., Correia, M., Dias, E., & Oliveira, N. (2026). Drug-eluting versus plain balloon angioplasty for haemodialysis vascular access stenosis: a retrospective analysis. Angiologia e Cirurgia Vascular, 22(3). https://doi.org/10.48750/acv.710
Vancouver
Boal R, Silva M, Pereirinha B, Maximiano P, Correia M, Dias E, et al. Drug-eluting versus plain balloon angioplasty for haemodialysis vascular access stenosis: a retrospective analysis. Angiologia e Cirurgia Vascular. 2026;22(3). doi:10.48750/acv.710
BibTeX
@article{Boal2026,
author = {Boal, Roberto and Silva, Manuel and Pereirinha, Bruno and Maximiano, Pedro and Correia, Mafalda and Dias, Emanuel and Oliveira, Nelson},
title = {Drug-eluting versus plain balloon angioplasty for haemodialysis vascular access stenosis: a retrospective analysis},
journal = {Angiologia e Cirurgia Vascular},
year = {2026},
volume = {22},
number = {3},
doi = {10.48750/acv.710}
}
EUVIMED